Loading…
Abbott and Tandem Diabetes Care announced plans to develop and commercialize integrated diabetes solutions combining Abbott's FreeStyle Libre glucose sensing technology with Tandem's insulin delivery systems.
“Abbott and Tandem Diabetes Care announced today that they intend to develop and commercialize integrated diabetes solutions that combine Abbott's world-leading glucose sensing technology with Tandem's innovative insulin delivery systems.”abbott.mediaroom.com
Summarized from public sources; check the original articles before acting on it.